CAPhO IDEA Virtual Workshop Inclusion, Diversity, Equity and Access (IDEA) in Oncology Pharmacy Virtual Workshop

BOPA and CAPhO ongoing collaboration

CAPhO will be hosting a virtual half-day workshop on IDEA (Inclusion, Diversity, Equity and Accessibility) in Oncology Pharmacy on Saturday, June 1st from 9am-2:30pm MDT (4pm – 9:30pm BST).  CAPhO are charging their members a reduced fee of $19 CDN (it is $99 for non-members) and CAPhO have extended the reduced fee to BOPA members also.

If you wish to attend the virtual workshop please see joining instructions below:

https://www.capho.org/article/news/capho-idea-virtual-workshop-0

When BOPA members click on the “Register for IDEA Workshop” button, they will be taken to a CAPhO registration page. If they have not attended any CAPhO events before, they will have to click on “Create a Login” to set up a username/password. When they get to the fee page, they should select “CAPhO Member.” The description on this page indicates that both CAPhO and BOPA members can register for the reduced fee. 

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article